CRMAX
Price
$12.86
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
FSMAX
Price
$94.79
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

CRMAX vs FSMAX

Header iconCRMAX vs FSMAX Comparison
Open Charts CRMAX vs FSMAXBanner chart's image
CRM Small/Mid Cap Value I
Price$12.86
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Fidelity Extended Market Index
Price$94.79
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
CRMAX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CRMAX vs. FSMAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a StrongBuy and FSMAX is a Buy.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. CRMAX (187M). FSMAX pays higher dividends than CRMAX: FSMAX (1.10) vs CRMAX (0.59). CRMAX was incepted earlier than FSMAX: CRMAX (20 years) vs FSMAX (13 years). CRMAX is a more actively managed with annual turnover of: 42.00 vs. FSMAX (18.00). FSMAX has a lower initial minimum investment than CRMAX: FSMAX (0) vs CRMAX (2500). FSMAX annual gain was more profitable for investors over the last year : 37.46 vs. CRMAX (35.01). FSMAX return over 5 years is better than : 54.93 vs. CRMAX (13.84).
CRMAXFSMAXCRMAX / FSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years13 years-
Gain YTD21.09221.43298%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets187M40B0%
Annual Yield % from dividends0.591.1054%
Returns for 1 year35.0137.4693%
Returns for 3 years-18.342.73-671%
Returns for 5 years13.8454.9325%
Returns for 10 years-26.2686.34-30%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNTS0.670.06
+9.30%
Momentus
HPP4.210.17
+4.21%
Hudson Pacific Properties
K81.180.15
+0.19%
Kellanova
WDFC285.73-4.39
-1.51%
WD-40 Company
NVCT10.67-0.31
-2.82%
Nuvectis Pharma